• Notifications
    This feature only available to registered users.
  • Alerts
    This feature only available to registered users
  • Welcome Guest!
  • Login Signup

Stock [ BUY ] / [ SELL ] Trading Strategies
. [ Show Details ]

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:

Indicator Windows:

ENZ [ Enzo Biochem Inc ]
Last Trade 2.8 Date 3/6/2021
Change % 1.82 % Price Change 0.05
Open 2.78 52 Week High 4.85
High 2.83 52 Week Low 1.56
Low 2.61 Type stock
Volume 310476 Average Volume 346002
Prev Close 2.75 Stock Exchange NYSE
Bid 2.58 Ask 2.9
Bid Size 2 Ask Size 1
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 1.2322 Book Value Yield 0.4481
Buy Back Yield CAPE Ratio
Cash Return -0.1601 Cash Flow per Share -0.3416
Cash Flow Yield -0.1242 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -0.1564 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue 1.3927 EV / Total Asset 1.0365
Expected Dividend Growth Rate Free Cash Flow per Share -0.3942
Free Caash Flow Ratio Free Cash Flow Yield -0.1433
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 2.231716 PB Ratio 10 Year Growth 0.02342
PB Ratio 3 Year Growth 2.104032 Cash Ratio 3 Year Average 287.8598
Price to Cash Flow Ratio PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average 40.850958 PE Ratio 10 Year Growth
PE Ratio 10 Year High 142.5 PE Ratio 10 Year Low 5.226804
PE Ratio 1 Year Avg 87.636363 PE Ratio 1 Year High 129.0
PE Ratio 1 Year Low 60.666667 PE Ratio 3 Year Avg 86.119841
PE Ratio 5 Year Avg 41.403083 PE Ratio 5 Year High 142.5
PE Ratio 5 Year Low 5.226804 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg 121.955033 Price Change 1 Month 0.941781
Price to Cash Ratio 2.868654 Price / EBITDA
Price to Sales Ratio 1.555639 Price to Sales Ratio 10 Year Growth -0.006027
Price to Sales Ratio 3 Year Avg 1.742858 Price to Sales Ratio 5 Year Avg 41.403083
Sale per Share 1.7678 Sales Yield 0.6428
Sustainable Growth Rate -0.2996 Tangible Book Value per Share 1.067
Tangible Book Value per Share 3 year Avg 1.3166 Tangible Book Value per Share 5 year Avg 1.46
Total Asset per Share 2.3698 Total Yield
Working Capital per Share 0.7661 Working Capital per Share 3 Year Avg 1.0408
Working Capital per Share 5 Year Avg 1.2299 Beta 0.988954
Company Profile

Enzo Biochem, Inc., a life sciences and biotechnology company, engages in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. The company operates in three segments: Enzo Life Sciences, Enzo Clinical Labs, and Enzo Therapeutics. The Enzo Life Sciences segment manufactures, develops, and markets functional biology and cellular biochemistry products and tools to research and pharmaceutical customers. It offers products applied in the fields of antibiotics, autophagy, cancer, cell cycle, cell death, cell signaling, cell trafficking, genomics/molecular biology, immunology, inflammation, lipid signaling, neurobiology, protein degradation, ROS/RNS, and stress/heat shock. The Enzo Clinical Labs segment offers routine and esoteric clinical laboratory tests or procedures used in general patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. It also operates a full-service clinical laboratory, a network of 30 patient service centers, a stand alone or rapid response laboratory, and a full-service phlebotomy department. The Enzo Therapeutics segment engages in the research and development of various therapeutic drug candidates based on cell signaling, immune regulation, and gene regulation for the treatment of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem, Inc. sells its products through direct sales force and distributors in the United States, Switzerland, the United Kingdom, Belgium, and Germany. The company was founded in 1976 and is headquartered in New York, New York.